Rigel Pharmaceuticals, Inc. ( RIGL) - Stock Earnings
RIGL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
RIGL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 268.1 million USD | 69.8 million USD |
| 2026Q1 | 8.7 million USD | 58.8 million USD |
| 2026Q2 | 17.3 million USD | 78.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RIGL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -25.1 million USD | 116.9 million USD |
| 2024 | 17.5 million USD | 179.3 million USD |
| 2025 | 367.0 million USD | 294.3 million USD |
| 2026 Est. | — | — |
RIGL
Price: $45.89
Earnings Per Share: 16.89 USD
P/E Ratio: 2.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.8 million
Ebitda: -17.7 millionMarket Capitalization: 872.4 million